Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis—a post-hoc analysis of a randomized, controlled trial

BACKGROUND: Calcimimetic therapy with etelcalcetide (ETEL) has been shown to attenuate the advancement of left ventricular (LV) hypertrophy in hemodialysis patients measured by cardiac magnetic resonance (CMR). The aim of the study was to evaluate whether this effect is accompanied by alterations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörr, Katharina, Kammerlander, Andreas, Lauriero, Francesco, Lorenz, Matthias, Marculescu, Rodrig, Beitzke, Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626812/
https://www.ncbi.nlm.nih.gov/pubmed/37932788
http://dx.doi.org/10.1186/s12968-023-00975-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626812/
https://www.ncbi.nlm.nih.gov/pubmed/37932788
http://dx.doi.org/10.1186/s12968-023-00975-4

Ejemplares similares